Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
Aims: Cisplatin is a frontline chemotherapeutic utilized to attenuate multiple cancers in the clinic. Given its side -effects, a new cisplatin formulation which could prevent cytotoxicity, metabolic deficiencies and metastasis is much needed. This study investigates whether nanocarriers can provide...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Elsevier
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/45315/ https://doi.org/10.1016/j.heliyon.2024.e28171 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|